Third, both the rates of, and factors associated with, treatment discontinuation were similar for GLP-1 receptor agonists and SGLT2 inhibitors, indicating that patient-specific factors, rather than drug-specific factors (such as side-effects), are driving treatment discontinuation
Listen and download: | American Society of Health-System Pharmacists
Integration with traditional biomarkers and future outlook As a new-generation biomarker system, digital biomarkers have broader acquisition settings, higher temporal resolution, and higher sensitivity, enabling continuous, dynamic, and precise characterization of disease progression
FAQs Q: Are GLP-1 drugs safe to take long-term
Like our faces, our lips are subject to environmental damage and tend to lose moisture as we age
Certain patients, such as those who are actively increasing their dose or have other conditions that may delay gastric emptying, may need to stop taking the medication in advance to avoid increased risks during anesthesia